{
  "variants": [
    {
      "gene": "SNCA",
      "protein_change": "E46K",
      "variant_string_id": "SNCA:E46K",
      "evidence_strength": "PS3_supporting",
      "assessment_steps": [
        {
          "step": "1",
          "description": "The disease mechanism is linked to α-synuclein polymerization into amyloid fibrils. The study shows that E46K increases fibrillization, which is associated with disease.",
          "justification": "The abstract states that mutations in the amino-terminal region affect the ability to polymerize, which is central to the disease mechanism."
        },
        {
          "step": "2",
          "description": "The assay (fibrillation) is a standard method for studying amyloid formation, making it applicable to the disease mechanism.",
          "justification": "Fibrillation assays are widely used to assess protein aggregation, which is relevant to α-synuclein pathology."
        },
        {
          "step": "3",
          "description": "The study lacks explicit controls (wild-type vs. mutant) or replicates, but the effect is directly observed in the context of the mutation.",
          "justification": "The abstract does not mention controls or replicates, so Step 3a is not met. However, the effect is demonstrated in the text."
        },
        {
          "step": "4",
          "description": "The effect of E46K on fibrillization is significant but less pronounced than A53T, leading to supporting evidence.",
          "justification": "The study shows a direct functional effect, but without controls or statistical analysis, the evidence is classified as supporting."
        }
      ]
    },
    {
      "gene": "SNCA",
      "protein_change": "A53T",
      "variant_string_id": "SNCA:A53T",
      "evidence_strength": "PS3_supporting",
      "assessment_steps": [
        {
          "step": "1",
          "description": "The disease mechanism is linked to α-synuclein polymerization, and A53T increases fibrillization more than E46K.",
          "justification": "The abstract explicitly states that A53T has a stronger effect on fibrillization than E46K."
        },
        {
          "step": "2",
          "description": "The assay (fibrillation) is a standard method for studying amyloid formation, making it applicable to the disease mechanism.",
          "justification": "Fibrillation assays are widely used to assess protein aggregation, which is relevant to α-synuclein pathology."
        },
        {
          "step": "3",
          "description": "The study lacks explicit controls or replicates, but the effect is directly observed in the context of the mutation.",
          "justification": "The abstract does not mention controls or replicates, so Step 3a is not met. However, the effect is demonstrated in the text."
        },
        {
          "step": "4",
          "description": "The effect of A53T on fibrillization is more pronounced than E46K, leading to supporting evidence.",
          "justification": "The study shows a direct functional effect, but without controls or statistical analysis, the evidence is classified as supporting."
        }
      ]
    },
    {
      "gene": "SNCA",
      "protein_change": "E83K",
      "variant_string_id": "SNCA:E83K",
      "evidence_strength": "PS3_supporting",
      "assessment_steps": [
        {
          "step": "1",
          "description": "The disease mechanism is linked to α-synuclein polymerization, and E83K increases fibrillization but perturbs mature amyloid properties.",
          "justification": "The abstract states that E83K increases polymerization but alters mature amyloid characteristics, indicating a functional effect."
        },
        {
          "step": "2",
          "description": "The assay (fibrillation) is a standard method for studying amyloid formation, making it applicable to the disease mechanism.",
          "justification": "Fibrillation assays are widely used to assess protein aggregation, which is relevant to α-synuclein pathology."
        },
        {
          "step": "3",
          "description": "The study lacks explicit controls or replicates, but the effect is directly observed in the context of the mutation.",
          "justification": "The abstract does not mention controls or replicates, so Step 3a is not met. However, the effect is demonstrated in the text."
        },
        {
          "step": "4",
          "description": "The effect of E83K on fibrillization is significant but less pronounced than A53T, leading to supporting evidence.",
          "justification": "The study shows a direct functional effect, but without controls or statistical analysis, the evidence is classified as supporting."
        }
      ]
    },
    {
      "gene": "SNCA",
      "protein_change": "E83A",
      "variant_string_id": "SNCA:E83A",
      "evidence_strength": "PS3_supporting",
      "assessment_steps": [
        {
          "step": "1",
          "description": "The disease mechanism is linked to α-synuclein polymerization, and E83A increases fibrillization but perturbs mature amyloid properties.",
          "justification": "The abstract states that E83A increases polymerization but alters mature amyloid characteristics, indicating a functional effect."
        },
        {
          "step": "2",
          "description": "The assay (fibrillation) is a standard method for studying amyloid formation, making it applicable to the disease mechanism.",
          "justification": "Fibrillation assays are widely used to assess protein aggregation, which is relevant to α-synuclein pathology."
        },
        {
          "step": "3",
          "description": "The study lacks explicit controls or replicates, but the effect is directly observed in the context of the mutation.",
          "justification": "The abstract does not mention controls or replicates, so Step 3a is not met. However, the effect is demonstrated in the text."
        },
        {
          "step": "4",
          "description": "The effect of E83A on fibrillization is significant but less pronounced than A53T, leading to supporting evidence.",
          "justification": "The study shows a direct functional effect, but without controls or statistical analysis, the evidence is classified as supporting."
        }
      ]
    }
  ]
}